Business
DarioHealth Appoints Two New Board Members
Yadin Shemmer & Adam K. Stern to serve until the 2020 Annual Meeting of Stockholders NEW YORK, March 5, 2020 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO),
About this update from Dariohealth Corp.
[{"type":"text","content":"Yadin Shemmer & Adam K. Stern to serve until the 2020 Annual Meeting of Stockholders\n\n\nNEW YORK, March 5, 2020 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board members effective immediately until the 2020 Annual Meeting of stock holders.\n \n \n\"We are very pleased to welcome Yadin and Adam to Dario's board, and look forward to leveraging their dynamic leadership experience in digital health and extensive background in finance as we continue to develop into a leading global digital therapeutics company,\" said Erez Raphael, CEO of DarioHealth. \nMr. Shemmer has served in several senior operating roles across the digital health industry. From 2017 to 2019, Mr. Shemmer served as Chief Executive Officer of Mango Health, a mobile platform for medication management and patient support. \nPrior to Mango Health, Mr. Shemmer was President of the consumer business at Everyday Health, a provider of digital health and wellness solutions. Previously, Mr. Shemmer co-founded Better2Know, a digital diagnostic services platform in the U.K. Yadin began his career at Broadview International, a boutique investment bank serving the information technology industry. He holds an M.B.A from London Business School and a B.A from the University of Pennsylvania. \n\"Chronic disease is a daily challenge for millions of people around the world. Addressing this challenge requires novel solutions that transform the healthcare experience for consumers and provide intelligent connectivity to payers and care teams. Dario's solution meets this need by providing consumers with daily support while enabling care teams to monitor their populations and intervene appropriately. \" said Mr. Shemmer. \"I am excited to join the Board and support Dario's mission of transforming the experience and management of chronic disease.\" \nMr. Stern is CEO of SternAegis Ventures and Head of Private Equity Banking at Aegis Capital Corp. He has been a venture capitalist and investment banker for more than 30 years with an emphasis on the technology and life sciences industries. Mr. Stern is a current director of Matinas Biopharma, Aerami Therapeutics, Adgero Biopharm, and Hydrofarm Holdings. Between October 2011 and May 2014, Mr. Stern ...